Palisade Bio (PALI) Interest Expenses (2010 - 2026)
Palisade Bio's (PALI) quarterly Interest Expenses came in at $1000.0 in Q1 2026, little changed year-on-year from $1000.0 in Q1 2025, and down 80.0% on a QoQ basis from $5000.0 in Q4 2025.
Palisade Bio (PALI) Interest Expenses (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Interest Expenses data on file, last reported at $1000.0 in Q1 2026.
- On a quarterly basis, Interest Expenses changed 0.0% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was $13000.0, a 8.33% increase from a year earlier, with the FY2025 full-year figure at $27.3 million, down 15.96% from the prior year.
- Interest Expenses for Q1 2026 stood at $1000.0, down from $5000.0 in the prior quarter.
- Over the last five years, Interest Expenses for PALI reached as high as $35.6 million in Q1 2023 and fell as low as $1000.0 in Q1 2025.
- Historically, Interest Expenses has averaged $2.1 million across 5 years, with a median of $5000.0 in 2024.
- Across the five-year window, Interest Expenses jumped 82793.02% in 2023 and tumbled 99.96% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then surged by 66.67% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025, then tumbled by 80.0% to $1000.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $1000.0 in Q1 2026, $5000.0 in Q4 2025, and $5000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |